Connected Places
News
Leaders and innovators gather for the Connected Places Summit
Over 200 speakers and thought leaders from the worlds of transport, the built environment, and cities are set to join the Summit in London and online. Network Rail Chief Executive Sir Andrew Haines leads a stellar line-up of speakers to kick off the second Connected Places Summit in London today. Sir Andrew is in conversation with Connected Places Catapult’s Chief Executive, Erika Lewis this morning, exploring the importance of innovation in shaping the future of Britain’s railways.
High Value Manufacturing
News
Future-Proofing UK Food Production: Embracing Innovation to Strengthen Domestic Capabilities
Bhavnita Patel, in the Food and Drink Federation’s “Future Factory” report, highlights how digital innovation, AI, and automation can help UK food producers boost efficiency, address skills gaps, and drive long-term growth. High Value Manufacturing Catapult is supporting businesses to turn these opportunities into reality.
Medicines Discovery
News
Medicines Discovery Catapult achieves ISO 45001 health and safety standard
Medicines Discovery Catapult has been awarded ISO 45001, an international standard for occupational health and safety. The standard is the world’s first international standard for occupational health and safety. Independently certified, it provides a framework to increase safety, reduce workplace risks and enhance health and wellbeing in the workplace.
Digital
News
Digital Catapult becomes one of the first sites to join national 6G research platform
Digital Catapult, a deep tech innovation organisation, has become one of the first sites to connect to the JOINER (Joint Open Infrastructure for Networks Research) platform, advancing the development and use of data-driven and open future networks in the UK. Led by the University of Bristol’s Smart Internet Lab, the platform is set to accelerate the adoption of future communication and networking technologies, including 6G, nationwide.
Cell and Gene Therapy
News
Network established to identify opportunities for regulation to support innovation within advanced therapies
A new network will foster collaboration among regulators, industry, and researchers to ensure there is a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these innovative treatments. Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and the Birmingham Health Partners Centre for Regulatory Science and Innovation (CRSI) established the network with funding from Innovate UK and support from the MHRA.
Offshore Renewable Energy
News
A dozen North East businesses chosen for award-winning offshore renewables supply chain programme
Twelve businesses in the North East of Scotland targeting success in the offshore renewable energy market have been selected for the award-winning Fit For Offshore Renewables (F4OR) supply chain support programme. The programme is open to companies looking to break into the offshore renewable energy sector, scale up an existing presence in the industry, or make the transition to renewables from other sectors, such as oil and gas. F4OR is delivered by the Offshore Renewable Energy Catapult, and has supported more than 150 companies over the last five years who have, on average, experienced an increase in turnover of 28% as a result of securing new contracts and many have gone on to become market-leading suppliers to the offshore wind sector.
Page 1 of 6